MEDRAD Innovation Journey - from start-up to Industry Standard: Mountain Climbing, Spelunking, Over the Horizon Home Runs, and creating a “DC-3 Effect”

Abstract

Medrad was a pioneer and is now a current leader in the medical imaging industry; which, after acquisition is now part of Bayer Radiology. In this case study, we describe the customer, user, and ecosystem centric processes employed by the company to identify underserved, unserved, and as yet unimagined markets to commercialize its technology. The evolution begins at the start-up stage, follows the development and growth stages, and includes the history, philosophy, and principles that created a global leader in med tech innovation. You will see the journey described through several metaphors - “mountain climbing, spelunking, and over the horizon home runs”. We also describe the importance of the “DC-3 effect” which has been used in the aerospace industry to describe the importance of assembling all the right elements, similar to an ecosystem, to build an industry standard platform. Many of the processes employed by Medrad utilized innovation principles before they became well developed and popularized; they sought “blue oceans”, understood disruption, and utilized design thinking principles. The company also adopted the balanced scorecard approach to align corporate vision and goals before the methodology became common in many industries.
https://doi.org/10.5912/jcb857
Requires Subscription or Fee PDF

Unless specified by prior arrangement, the author agrees to the following terms and assurances:

  1. For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
  2. I/we further give to the following assurances
    1. I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
    2. I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
    3. To the best of my/our knowledge, all the facts in the contribution are true and accurate;
    4. The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
    5. Nothing in the contribution is obscene or libellous;
    6. Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
    7. I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).
* Works by US government employees prepared as part of official duties are in the public domain and the authors are therefore exempt from copyright assignment.